ARUP enters partnership to offer deCODE's DNA-based prostate cancer risk assessment t
deCODE genetics and ARUP Laboratories today announced a partnership through which ARUP will offer deCODE's DNA-based prostate cancer risk assessment test to its clients nationwide.